Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011

PHASE2CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

Fluviral 2010/11 Tri-valent Seasonal Influenza vaccine

Vaccination of .05mL of Fluviral vaccine will be injected once at either visit 1 or 2 depending upon randomization in the deltoid muscle of the non-dominant arm

BIOLOGICAL

Fluviral 2010/11 Tri-valent Seasonal Influenza vaccine

Vaccination of .05mL of Fluviral vaccine will be injected once at either visit 1 or 2 depending upon randomization in the deltoid muscle of the non-dominant arm

Trial Locations (5)

Unknown

ACHIEVE Research, Alberta Children's Hospital, Calgary

Vaccine Evaluation Center, Vancouver

The Ottawa Hospital Research Institute, Ottawa

McGill University Health Centre - Vaccine Study Centre, Montreal

Unité de Recherche en Santé Publique, Québec

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of British Columbia

OTHER

NCT01140009 - Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011 | Biotech Hunter | Biotech Hunter